Board Stats

Navidea Biopharmaceuticals, Inc.

Y! IH NAVB EXPRESS NAVB Advanced Due Diligence NAVB Oldtimers Lounge TME Macrophage Therapeutics Tx Potential-McGrath Basic Immune Cell Functions Immune Cells M1 and M2 Basics 2022- Magical Mystery Tour of Macrophges

NAVB / Message Board

BOARD

GROUPS

Written By On Topic Only -- All Messages

Hide Replies

Keyword
Subject

Between			and
Rec'd By

Authored By
Minimum Recs

MSG #	SUBJECT	TYPE	AUTHOR	SENTIMENT	RECS	DATE POSTED
40562	2nd gen CAR-M engineered macrophage attempt resolve TME M1 shaping-offsite target iss	GN	moneyonomics		2	12/4/2023 2:17:24 PM

40561	Re: Another Leishmaniasis study from Sacks and Lee involving Manocept	GN	moneyonomics		2	12/3/2023 1:14:21 PM

40560	Another Leishmaniasis study from Sacks and Lee involving Manocept	GN	ddin		2	12/3/2023 11:32:40 AM

40559	3D-Printed Scaffolds with Dex conjugate Modulates M1/M2 Activation for Bone regenerat	GN	moneyonomics		3	12/2/2023 4:03:10 PM

40558	TAMs at forefront in oncology research-bears promise of transforming cancer treatment	GN	moneyonomics		3	12/2/2023 2:23:48 PM

40557	Netherlands 68GA-tilmanocept PET/CT P3 trial for SLND in Endometrial Cancer--progress	GN	moneyonomics		2	12/1/2023 7:44:58 PM

40556	Re: More on CRG Settlement	GN	AG_Trader10		1	12/1/2023 4:19:39 PM

40555	Re: SEC filing on CRG/Kim Scott agreements published-made cash payment of $920,000 to CRG	GN	dfruitman		0	12/1/2023 3:26:51 PM

40554	SEC filing on CRG/Kim Scott agreements published-made cash payment of $920,000 to CRG	GN	moneyonomics		4	12/1/2023 2:44:59 PM

40553	Re: More on CRG Settlement	GN	ZombieInvestor		0	12/1/2023 2:34:36 PM

Go to Msg #

BOARDS Sign In for Filters